Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostair in Idiopathic Pulmonary Fibrosis
NCT02048644Phase 2Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Mar 2014
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of beclometasone dipropionate + formoterol in idiopathic pulmonary fibrosis (IPF), sponsored by Hull University Teaching Hospitals. Started Mar 2014; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02048644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048644.